We are live on ! Find out more
CO

Global Cord Blood Corporation
CO

Delisted

CO was delisted on the 23rd of September, 2022.

Back to rankings

2 hedge funds and large institutions have $12.9K invested in Global Cord Blood Corporation in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

8% less capital invested

Capital invested by funds: $14K → $12.9K (-$1.17K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LC
Luminist Capital
Michigan
+$157

Top Sellers

No sellers this quarter

CO Hedge Fund Activity: Q2 2026 in Review

2 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2026, worth a combined $12.9K — down 8.3% from $14K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Luminist Capital, opening a new position worth an estimated $157.

  • 2 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2026, up from 1 in Q1 2026.
  • Funds reported $12.9K of Global Cord Blood Corporation stock for Q2 2026, down 8.3% quarter-over-quarter.
  • 1 fund opened new Global Cord Blood Corporation positions in Q2 2026 and 0 closed out, a net change of +1 holder.
  • The largest Global Cord Blood Corporation buyer in Q2 2026 was Luminist Capital, an estimated $157 added.

Based on aggregated 13F filings for Q2 2026.